Chris Schott
Stock Analyst at JP Morgan
(1.22)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
LLY Eli Lilly | Reiterates: Overweight | 1100 1100 | 635.48 | 73.1% | 20 | Aug 8, 2025 | |
PRGO Perrigo | Maintains: Overweight | 38 35 | 22.01 | 59.02% | 9 | Aug 7, 2025 | |
IDXX IDEXX Laboratories | Maintains: Overweight | 550 675 | 652.43 | 3.46% | 8 | Aug 4, 2025 | |
REGN Regeneron Pharmaceut... | Maintains: Overweight | 950 800 | 546.18 | 46.47% | 8 | Jun 9, 2025 | |
TEVA Teva Pharmaceutical ... | Upgrades: Overweight | 21 23 | 16.42 | 40.07% | 10 | May 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 185 175 | 128.03 | 36.69% | 4 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 120 130 | 120.57 | 7.82% | 6 | Mar 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 9 12 | 8.85 | 35.59% | 2 | Feb 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 210 200 | 198.62 | 0.69% | 2 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 225 230 | 149.01 | 54.35% | 2 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 18 20 | 9.02 | 121.73% | 2 | Sep 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 45 42 | 36.2 | 16.02% | 4 | Feb 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 270 | 285.1 | -5.3% | 1 | Oct 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 36 34 | 24.61 | 38.16% | 7 | Oct 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 120 125 | 80.06 | 56.13% | 6 | Feb 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 13 14 | 9.87 | 41.84% | 2 | Nov 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 13 11 | 0.88 | 1150% | 4 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 20 | 17.11 | 16.89% | 3 | Oct 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 175 150 | 119.99 | 25.01% | 3 | Oct 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Jul 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 74 78 | 45.94 | 69.79% | 4 | Oct 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 110 | 116.3 | -5.42% | 1 | Sep 9, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 700 950 | 7.14 | 13205.32% | 4 | May 27, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 5 | May 19, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | May 19, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | May 13, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 9 | n/a | n/a | 6 | May 13, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 45 50 | 25.19 | 98.49% | 3 | Nov 2, 2018 |